The science behind the recommendations

Azelaic acid

What it does and how:
Azelaic acid clears breakouts and fades the marks they leave by working through three separate mechanisms at once: it suppresses the acne bacteria C. acnes in the pore, it calms inflammation by neutralizing the reactive oxygen molecules that drive redness, and it slows excess pigment production by interrupting tyrosinase, the enzyme that makes melanin. That combination is why it's the single best-suited active for this problem, treating the breakout and the mark through independent routes.

Evidence base:
Strong for both acne and redness. A 2023 systematic review of 43 randomized controlled trials found azelaic acid superior to vehicle for reducing inflammatory acne lesions and rosacea redness [1], and the pivotal phase III rosacea trials (around 1,200 subjects) showed a 15% gel cut inflammatory lesions by 51-58% over 12 weeks versus 39-40% for vehicle [2]. A separate trial of 20% azelaic acid in mild-to-moderate acne reduced total lesions by roughly 60% against placebo [3]. For dark marks specifically, the evidence is Moderate: a 2023 meta-analysis of six trials found 20% azelaic acid reduced melasma severity at least as well as hydroquinone, the long-standing pigment standard [4]. There is no qualifying evidence for azelaic acid on fine lines, so it earns no anti-aging claim [1].

Concentration that works:
The strongest evidence sits at prescription strength, 15-20% [2][3]. The common over-the-counter concentration is 10%, which is real but meaningfully weaker, so a 10% drugstore product shouldn't be expected to match a 15% prescription one [1]. Vehicle matters more here than for most actives: at the same percentage, a gel or foam outperforms a cream, because azelaic penetrates better from those bases.

Timeline:
Reduced inflammation and lesions around 4-6 weeks; meaningful lesion clearance and pigment fading by 12 weeks [2]. Mild stinging or itching in the first week or two is normal and settles; there's no true purge.

Who it's not for:
Among the best-tolerated actives there is, with no pregnancy contraindication (it's a preferred pigment active during pregnancy) [4]. It's understudied for post-inflammatory marks specifically in deeper, non-white skin, the exact population that relies on it most [1], so real-world results in Fitzpatrick IV-VI rest more on mechanism and clinical use than on dedicated trial data.

Key interactions:
Pairs well with niacinamide, which buffers the early stinging, and layers safely under a retinoid. It shouldn't be mixed into the same application as benzoyl peroxide.

Niacinamide

What it does and how:
Niacinamide evens tone and fades marks by interrupting the handoff of pigment from the cells that make it (melanocytes) to the surface skin cells that carry it up into view, a different route than the pigment-blockers, which is why it stacks well with them [6]. Alongside that, it reinforces the barrier by prompting your skin to make more of its own ceramides, and it calms inflammation, both of which matter when the goal is fading marks without provoking new ones [7].

Evidence base:
Strong for brightening and tone. The melanosome-transfer mechanism was established in a controlled trial [6], and a split-face trial found 4% niacinamide comparable to 4% hydroquinone for melasma [8]. A 12-week vehicle-controlled trial of 5% niacinamide showed significant improvement in tone, hyperpigmentation, and fine lines in photoaged skin [5]. Moderate for breakouts, where a head-to-head against 1% clindamycin found comparable anti-inflammatory effect with better tolerability [9], though the mechanism is anti-inflammatory rather than pore-clearing. Barrier and hydration evidence is Moderate-to-Strong [7].

Concentration that works:
2-5% is the studied range, with most trials at 4-5% [5][8][9]. There's no clear added benefit above 5% for these outcomes, and products at 10%+ are common but not well characterized in independent trials. It's stable and works across a wide pH, which is part of why it's so easy to combine.

Timeline:
Barrier and redness improvements at 2-4 weeks; pigment and tone changes on the longer 8-12 week arc; fine-line and texture change around 12 weeks [5].

Who it's not for:
Almost universally tolerated, with no contraindication in pregnancy or sensitive skin. The main data gap is the same Fitzpatrick IV-VI shortfall that runs through this whole category: the mechanism applies across skin tones, but dedicated trial data in deeper skin is thin relative to how often it's used there.

Key interactions:
Synergistic with nearly everything relevant here, like vitamin C, retinoids, ceramides, tranexamic acid, and exfoliating acids, and it actively reduces the irritation those last two can cause.

Vitamin C

What it does and how:
Vitamin C brightens skin and fades marks by slowing melanin production through tyrosinase suppression, and at the same time neutralizes the free-radical damage that daily UV inflicts, which is part of what drives uneven tone in the first place [12]. That antioxidant role is why it's a morning active: it backs up sunscreen rather than replacing it [13].

Evidence base:
Strong for brightening and tone, but with a critical caveat: that strength applies to L-ascorbic acid, the pure active form [12]. A 3-month vehicle-controlled trial of topical L-ascorbic acid showed significant improvement in fine lines and texture in photoaged skin [11]. The gentler derivatives (like the ethyl ascorbic acid and sodium ascorbyl phosphate found in lower-irritation serums) are more stable and more tolerable but weaker and slower, and their evidence is more limited; one trial of a magnesium ascorbyl phosphate derivative showed melasma lightening but as a weaker proxy than marketing implies [14]. "Vitamin C" isn't one claim; the form determines whether the evidence carries over.

Concentration that works:
For pure L-ascorbic acid, 10-20%, with 15% the most-studied and 20% the practical ceiling [10]. Below 10% the anti-aging and pigment evidence thins out. It needs a low pH (under 3.5) to penetrate, which is exactly what makes the strong versions sting reactive skin [10], and it oxidizes fast in air and light, so airless, opaque packaging is part of whether a product works at all. A serum that's turned yellow-brown has already lost potency. Derivatives trade some of that strength for stability and a kinder texture.

Timeline:
Visible brightening and tone evening at 4-8 weeks of daily use; mark and pigment correction on a longer 8-24 week arc, where it works as an adjunct to dedicated pigment actives rather than a replacement.

Who it's not for:
Low-pH L-ascorbic acid is a frequent problem for reactive and rosacea-prone skin; the fix is rerouting to a derivative, not pushing through. Population gaps: PIH-specific data in Fitzpatrick IV-VI is limited, and most pigment studies combine vitamin C with other actives, so isolating its solo contribution is genuinely hard [13].

Key interactions:
The vitamin C + vitamin E + ferulic acid combination is the best-evidenced topical antioxidant system there is, with the C/E pairing shown to give synergistic photoprotection beyond either alone [13]. Keep it away from benzoyl peroxide, which oxidizes it. Run it in the morning and a retinoid at night rather than layering them together.

Retinoids (adapalene, retinal)

What it does and how:
Retinoids fade marks and clear breakouts by binding receptors in your skin cells (the retinoic acid receptors) that speed up cell turnover and normalize how pores shed, which both clears the congestion behind breakouts and pushes pigmented cells up and out faster. The class isn't uniform: adapalene is a synthetic retinoid that's now available over the counter and is especially suited to acne; retinal (retinaldehyde) is one conversion step from the active form, so it's more potent than retinol but gentler than prescription tretinoin [20].

Evidence base:
Strong, the strongest of any active here for fine lines. The landmark trial established that topical tretinoin significantly improved photoaged skin over 16 weeks [15], and later trials confirmed efficacy at lower, better-tolerated concentrations [16]. For over-the-counter retinol, a 24-week vehicle-controlled trial of 0.3% showed significant improvement in fine lines and texture [18], and a systematic review found retinol meaningfully effective but with smaller effect sizes than tretinoin [17]. Retinal sits in a clinically meaningful middle ground, more potent than retinol and better tolerated than tretinoin, but on a smaller evidence base than either [20]. For acne and marks, the evidence is Strong for tretinoin and adapalene and Moderate for retinol.

Concentration that works:
Adapalene at 0.1% is the over-the-counter acne reference. Retinal is typically studied at 0.05-0.1% [20]. Over-the-counter retinol needs 0.3-0.5% with consistent use; below 0.1% there's little clinical support [18]. Retinol and retinal both oxidize in light and air, so airless, opaque packaging is mandatory, and a poorly stabilized formula may deliver almost nothing.

Timeline:
A purge of existing congestion is expected in acne-prone skin in the first 4-8 weeks. Dryness, flaking, and redness are normal in the first 2-6 weeks and are managed by starting at 1-2x a week and building slowly. Visible tone and texture change comes at 8-12 weeks; meaningful line improvement at 16-24 weeks [15].

Who it's not for:
A hard stop in pregnancy, breastfeeding, or when trying to conceive, for every form including over-the-counter retinol. Contraindicated on active eczema or a severely compromised barrier until that's repaired, which is exactly why the burned-out, barrier-first profile holds off entirely. Retinoids raise UV sensitivity, so daily SPF is required rather than optional. The population gap that matters most here: the risk of a retinoid's early purge causing post-inflammatory marks is higher in Fitzpatrick IV-VI and isn't well characterized in trial populations, one more reason deeper skin often routes to azelaic first.

Key interactions:
Niacinamide reduces retinoid redness without blunting its effect, a well-studied pairing. Don't combine with benzoyl peroxide (except adapalene, which is BPO-stable) or layer over an exfoliating acid the same night. Apply to dry skin, pea-sized, and never with a roller or massage tool.

Salicylic acid

What it does and how:
Salicylic acid clears breakouts by dissolving the oil and dead skin clogging the pore, and it can get there because it's oil-soluble and penetrates into the follicle itself, something the water-soluble acids can't do at any strength. That follicular reach is why it's the targeted choice for congestion and oily skin.

Evidence base:
Strong for comedonal (clogged-pore, non-inflamed) acne and oiliness; that's its lane. Comparative peel trials show salicylic acid effective for acne with good tolerability [21], and trials of newer leave-on delivery systems found a 2% formulation comparable to adapalene for mild-to-moderate acne [22]. It's only indirectly useful on the marks themselves, helping through turnover but not as a dedicated pigment-blocker, which is why the humid-climate profile pairs it with azelaic rather than leaning on it alone.

Concentration that works:
0.5-2% for leave-on over-the-counter use, with 2% the practical ceiling; the 20-30% you'll see referenced is for in-office peels and doesn't transfer to daily use [21]. It works best at pH 3-4.

Timeline:
Oiliness and pore feel often improve within 1-2 weeks; clogged-pore lesions at 4-8 weeks.

Who it's not for:
Better in oily and acne-prone skin than dry or sensitive; it's a poor fit for a compromised barrier, active eczema, or rosacea-prone skin, where it tends to sting and over-dry. Conservative use is the convention in pregnancy. The evidence is thinner than its popularity suggests for long-term use and across diverse skin tones.

Key interactions:
Works with niacinamide (which softens the dryness) and with benzoyl peroxide for acne. The main risk in combination is cumulative irritation, not chemical conflict, so it's spaced apart from the morning azelaic in the humid-climate routine rather than stacked.

Tranexamic acid

What it does and how:
Tranexamic acid fades dark marks by interrupting a different pigment pathway than the other brighteners: it blocks the plasmin and UV-triggered signaling that tells pigment cells to ramp up, which makes it especially suited to sun-driven and stubborn discoloration [25]. It has almost no irritation profile, which is its real advantage for this problem.

Evidence base:
Strong for marks and melasma. A 2024 meta-analysis of 25 trials confirmed topical and oral tranexamic acid measurably reduce melasma severity [24], and a 12-week trial of 5% topical tranexamic acid cut melasma severity by roughly half versus vehicle [23]. It has no acne mechanism, so it covers the marks but not the breakouts, the trade-off named in the profiles that use it.

Concentration that works:
2-5% topically, strongest at 3-5% [23]. The evidence is notably stronger in combination with other pigment actives than as a solo ingredient [26]. It needs a pH under about 5.5 to stay stable. One important distinction: the dramatic results you may have read about often come from oral tranexamic acid, which doesn't transfer to topical product claims.

Timeline:
Reduced redness around 4-6 weeks; visible pigment fading at 8-12 weeks [25]. No purge, occasional mild first-week irritation that resolves.

Who it's not for:
Topical use is well tolerated and likely fine in pregnancy (oral is avoided). The population gap cuts both ways here: most trials studied Fitzpatrick III-IV melasma, so both the fairest (I-II) and deepest (V-VI) skin tones are understudied [24], worth naming for anyone in those ranges relying on it.

Key interactions:
Synergistic with niacinamide and complementary to vitamin C (different pigment pathways) [26]. Avoid high-pH bases, which break it down.

Mandelic acid

What it does and how:
Mandelic acid resurfaces skin and fades marks by loosening the bonds between dead surface cells so they shed, and it does this more slowly and gently than other exfoliating acids because its molecule is roughly twice the size of glycolic acid's and therefore penetrates gradually. That slow delivery is the entire point: same exfoliation, far less irritation. It also has mild antibacterial activity, a bonus for acne-prone skin.

Evidence base:
Moderate for breakouts and for marks, with its strongest support in mild-to-moderate acne and post-acne pigment. A 2020 comparison found a 45% mandelic peel as effective as a 30% salicylic peel for acne, with better tolerability [27], and a systematic review of chemical peels supports combined mandelic-acid protocols for acne and post-acne pigment [28].

Concentration that works:
5-10% for daily or alternating-night leave-on use; the 20-45% figures are peel protocols that don't transfer to a serum [27]. Like all these acids, it needs a low pH (3-4) to work, and a neutralized formula is much weaker.

Timeline:
Acne and texture support at 4-8 weeks; mark and pigment support at 6-12 weeks or across serial peels.

Who it's not for:
It's the preferred exfoliating acid for deeper skin tones precisely because its low-irritation profile reduces the risk of triggering more marks, the reason it appears as the adjacent option in the Fitzpatrick V-VI profile rather than a stronger acid. Still real irritation potential, so not risk-free: delay it on a compromised barrier, patch test, and use sunscreen. The honest gaps: most evidence is peel-based rather than daily-serum-based, and Fitzpatrick-specific outcomes aren't consistently reported despite its reputation as the darker-skin-friendly acid [28].

Key interactions:
Pairs well with the pigment actives (azelaic, niacinamide, tranexamic acid) and synergistically with salicylic acid. With retinoids the issue is additive irritation, so they're typically separated.

Ceramides

What it does and how:
Ceramides repair the barrier by refilling the lipid mortar between your surface skin cells, the gaps where water escapes and irritants get in. They aren't treating the marks or the breakouts; they're the support layer that lets the actives that do treat them run without tipping skin into the irritation that causes more marks.

Evidence base:
Strong for barrier repair and reducing the rate at which skin loses water to the air. A double-blind trial showed a ceramide-dominant moisturizer significantly improved barrier function versus vehicle [29], a systematic review of 12 trials found ceramide formulations equal or better than comparison products [30], and atopic dermatitis guidelines name ceramide-containing emollients first-line baseline therapy [31].

Concentration that works:
This is the rare case where percentage isn't the right question, and most studies don't even report it. What matters is the lipid ratio: skin's barrier is roughly 3 parts ceramides to 1 part cholesterol to 1 part fatty acids, and formulas built toward that ratio outperform single-ceramide products [32]. A ceramide cream and a ceramide-labeled serum are not equivalent; cream and ointment vehicles deliver better barrier outcomes.

Timeline:
Measurable barrier and hydration improvement from a single application lasting up to 24 hours, with more substantial repair over about 28 days of twice-daily use [29].

Who it's not for:
Among the most universally tolerated ingredients there is, with no known irritation ceiling and no sensitization signal in the literature.

Key interactions:
Synergistic with niacinamide (which prompts your skin to make more of its own ceramides) and with the humectants below. No meaningful negative interactions.

Hyaluronic acid

What it does and how:
Hyaluronic acid plumps and hydrates by drawing water into the surface layers of skin and holding it there, since it's a humectant that binds many times its weight in water. Critically, it pulls moisture in but doesn't seal it, which is why in dry air it has to go under an occlusive moisturizer rather than working alone, the exact reasoning behind the dry-climate profile's sandwich and rich top layer [35].

Evidence base:
Strong for immediate surface hydration and plumping; that's a well-established humectant effect, not a corrective claim. A vehicle-controlled trial of a multi-molecular-weight topical formulation showed significant gains in hydration, elasticity, and roughness over 8 weeks [33]. Molecular weight changes the behavior: high-molecular-weight hyaluronic acid forms a surface film, while smaller fractions penetrate more [34]. It doesn't treat marks or breakouts, and it shouldn't be flagged for removal on dry or tight skin, since hydration is the goal there, not the problem.

Concentration that works:
Effective at low percentages (studied across roughly 0.1-2%), with molecular weight more determinative than concentration [34]; better formulas blend multiple weights to hydrate at different depths. The meaningful variable is what goes on top, because in dry or arid air a humectant without an occlusive seal can draw water from deeper skin and worsen the dryness it's meant to fix [35].

Timeline:
Immediate plumping and surface hydration, with measurable hydration gains over 2-4 weeks; the effect is maintained with use rather than building cumulatively.

Who it's not for:
Broadly safe and well tolerated across skin types.

Key interactions. Complementary with niacinamide and ceramides, and a near-universal hydration base. The one rule that matters: in dry climates, always seal it.

Ready to stop guessing which of these you actually need? Camellia maps your goals and skin signals to the right actives, then builds the routine around the products already on your shelf.

Common questions

Can I fade acne marks without breaking out again?

Yes, by choosing actives that treat both the marks and the breakouts and won't irritate your skin, since irritation itself is a cause of more marks. Azelaic acid and niacinamide are the safest dual-purpose starting points: azelaic calms the inflammation behind breakouts while slowing excess pigment [1], and niacinamide evens tone while reinforcing your barrier [6][7]. Adapalene (an over-the-counter retinoid) treats both through faster cell turnover if your skin is calm and your barrier intact.

How long does it take for dark marks from acne to fade?

Longer than most people expect: meaningful fading of post-acne marks generally takes 8-12 weeks of consistent use, and stubborn or deeper marks can take longer [4][25]. Brightening and overall tone usually improve before individual marks disappear, often around 4-8 weeks. The marks fade slowly because they sit in the deeper layers of skin and have to clear as those cells turn over, which no product can rush safely.

Can I use niacinamide and vitamin C together?

Yes. The old worry that they cancel each other out isn't supported at the concentrations in real products. They work through different pigment mechanisms, vitamin C slows melanin production while niacinamide blocks pigment from reaching the surface [6][12], so using them together is additive. A common setup is vitamin C in the morning and niacinamide at night, though many serums combine them.

What's the most affordable way to fade acne marks?

The most effective actives for this all exist at drugstore prices. Adapalene (around $14) treats breakouts and marks together; azelaic acid at 10% (around $12-20) does the same more gently; niacinamide (around $15) supports tone and barrier. A complete starter routine is a gentle cleanser, one of those actives, a moisturizer, and a daily sunscreen, which is non-negotiable because sun re-darkens marks faster than any serum fades them.

Is azelaic acid safe for sensitive skin?

Yes, it's one of the better-tolerated actives for sensitive and reactive skin, gentler than benzoyl peroxide, strong exfoliating acids, or retinoids, which is why it's often the first choice when those are too harsh [1]. Mild stinging or itching in the first week or two is normal and usually settles with continued use. If your barrier is actively compromised (tight, stinging, inflamed), repair it first before adding azelaic or anything else.

Where do I start if I've never used actives before?

Start with one active, not several, and introduce it slowly. For marks plus breakouts, azelaic acid or niacinamide are the gentlest effective entry points and don't require the careful ramp-up a retinoid does. If you start a retinoid like adapalene, begin at once a week and build up only as your skin tolerates it, since going faster causes the irritation that makes people quit [15][16]. Add a daily sunscreen from day one.

I have deeper skin and the marks bother me more than the breakouts. What's safest?

In deeper skin tones, the inflammation from harsh actives can itself trigger the dark marks you're trying to fade, so the safest approach favors low-irritation actives over the strongest-looking ones. Azelaic acid, tranexamic acid, niacinamide, and mandelic acid all fade marks with minimal irritation risk [1][24][27]; it's best to avoid strong exfoliating acids and high-strength, low-pH vitamin C, which are the most likely to backfire [10]. Daily sunscreen matters even more here, since unprotected sun darkens existing marks quickly.

Why does my barrier need to be healthy before I treat the marks?

Because inflammation is what locks marks in and triggers new ones, treating marks on a compromised barrier tends to make both worse. When skin is tight, stinging, or reactive, the first job is repair, ceramides, a humectant like hyaluronic acid, and niacinamide, with actives paused until the barrier is comfortable again (usually reassessed around 4 weeks) [29][31]. It feels like doing less, but a calm barrier is what lets every active afterward actually work.

If you're dealing with persistent breakouts or marks alongside other skin changes, a licensed dermatologist or qualified practitioner can help you sort out what's going on and what's right for your skin.

References

1. King S, et al. A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging. Journal of Cosmetic Dermatology. 2023.
2. Bjerke R, et al. Efficacy and safety of azelaic acid 15% gel as a new treatment for papulopustular rosacea (phase III studies). British Journal of Dermatology. 2004.
3. Sharquie KE, et al. Efficacy of topical azelaic acid gel in the treatment of mild-to-moderate acne vulgaris. Journal of Dermatology. 2007.
4. Albzea W, et al. Azelaic acid versus hydroquinone for managing patients with melasma: systematic review and meta-analysis of randomized controlled trials. Cureus. 2023.
5. Bissett DL, et al. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatologic Surgery. 2005.
6. Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. 2002.
7. Draelos ZD, et al. The effect of 2% niacinamide on facial sebum and barrier function. Journal of Cosmetic and Laser Therapy. 2006.
8. Navarrete-Solis J, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Journal of Drugs in Dermatology. 2011.
9. Khodaeiani E, et al. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. Indian Journal of Dermatology. 2013.
10. Pinnell SR, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatologic Surgery. 2001.
11. Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Archives of Otolaryngology - Head and Neck Surgery. 1999.
12. Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatologic Surgery. 2005.
13. Lin JY, et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. Journal of Investigative Dermatology. 2003. (Pigmentation mechanism review context: Telang PS. Vitamin C in dermatology. Indian Dermatology Online Journal. 2013.)
14. Kameyama K, et al. Inhibitory effect of magnesium L-ascorbyl-2-phosphate on melanogenesis in vitro and in vivo. Journal of Dermatology. 1996.
15. Kligman AM, et al. Topical tretinoin for photoaged skin. Journal of the American Academy of Dermatology. 1986.
16. Griffiths CEM, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (lower-concentration RCT). Archives of Dermatology. 1995.
17. Siddiqui A, et al. Cosmetic retinol versus prescription tretinoin: a systematic review. Journal of Cosmetic Dermatology. 2015.
18. Dhaliwal S, et al. Prospective, randomized, double-blind assessment of topical 0.3% retinol. British Journal of Dermatology. 2019.
19. Kang S, et al. Tazarotene 0.1% cream versus tretinoin 0.05% in photoaging. Journal of the American Academy of Dermatology. 2005.
20. Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Advances in Dermatology and Allergology. 2019.
21. Kessler E, et al. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderate facial acne vulgaris. Dermatologic Surgery. 2008.
22. Ye M, et al. Randomized study of 2% supramolecular salicylic acid hydrogel versus adapalene in mild-to-moderate acne. 2024.
23. Wu S, et al. Treatment of melasma with topical 5% tranexamic acid: a randomized controlled trial. Journal of the American Academy of Dermatology. 2020.
24. Zhang L, et al. Efficacy and safety of tranexamic acid for melasma: meta-analysis of 25 randomized controlled trials. Annals of Dermatology. 2024.
25. Chen Q, et al. Mechanisms and clinical applications of topical tranexamic acid: barrier repair via PAR-2 inhibition and reduction of PIH/rosacea redness (review). 2024.
26. Lee HC, et al. Combination of topical tranexamic acid 3% and hydroquinone 4% versus hydroquinone alone in melasma (split-face RCT). Dermatologic Surgery. 2019.
27. Dayal S, et al. Comparative study of 45% mandelic acid versus 30% salicylic acid peel in mild-to-moderate acne vulgaris. 2020.
28. Chen X, et al. Chemical peels for acne vulgaris: a systematic review. BMJ Open. 2018.
29. Draelos ZD, et al. A ceramide-containing moisturizer improves skin barrier function in dry skin (double-blind RCT). Journal of Cosmetic Dermatology. 2009.
30. Spada F, et al. Skin hydration and barrier outcomes with ceramide-containing formulations: systematic review of 12 RCTs. 2021.
31. Wollenberg A, et al. Consensus-based European guidelines for treatment of atopic eczema: ceramide-containing emollients as first-line baseline therapy. Journal of the European Academy of Dermatology and Venereology. 2020.
32. Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: ceramide-cholesterol-fatty acid ratio in barrier repair. American Journal of Clinical Dermatology. 2008.
33. Pavicic T, et al. Efficacy of cream-based topical hyaluronic acid formulations of different molecular weights in anti-wrinkle treatment. Journal of Drugs in Dermatology. 2011.
34. Bukhari SNA, et al. Hyaluronic acid, a promising skin rejuvenating biomedicine: molecular weight fractions and biological activity (review). Molecules. 2018.
35. Price RD, et al. The role of hyaluronic acid in skin physiology and barrier function (review literature). 2005.

_Reference note: citations are drawn from the Camellia Labs ingredient evidence library. Several entries flag industry-associated funding or modest sample sizes; where evidence strength was hedged above (Moderate, Possible, Weak), that hedge reflects those caveats.

‍